Concept Life Sciences Group acquired by Spectris plc

Concept Life Sciences, the integrated drug discovery, development and analytical services and environmental consultancy company, has announced the completion of its acquisition by Spectris plc , the productivity-enhancing instrumentation and controls company.

Spectris has acquired the Concept Life Sciences Group of companies from Equistone Partners and company management, for a purchase consideration of £163 million, on a debt and cash-free basis.

Concept represents a new, high-growth area for Spectris, and will become a separate operating company within its Materials Analysis segment where it has strong synergies with the activities of Malvern Panalytical. As a result of the acquisition, Concept’s customers will benefit from access to Malvern Panalytical’s expertise in molecular testing and analysis. In the medium term, Concept’s in-depth scientific offering, customer knowledge and application insights, combined with Malvern Panalytical’s deep domain knowledge and broad reach, will enable increased innovation across the combined group.

To read the full news release, click here.